Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2009

View Archived Issues

Bristol-Myers and ZymoGenetics sign collaboration for PEG-Interferon lambda in hepatitis C

FORMA and Novartis enter collaboration to develop inhibitors of protein-protein interactions

Cobalis to launch antiallergic drug PreHistin in February 2009

Boehringer Ingelheim divulges novel protein kinase inhibitors for use in treating cancer

Mochida and Shire sign Japanese license agreement for Lialda for ulcerative colitis

Daiichi Sankyo to make an open offer for acquisition of 20% of Zenotech common stock

FDA unable to complete review of Takeda's NDA for febuxostat by January 2009

CSL Behring receives FDA approval of RiaSTAP for acute bleeding episodes

Intercell signs exclusive agreement with Novartis for Japanese encephalitis vaccine

Pfizer receives FDA complete response letter for lasofoxifene in osteoporosis

Novel Jak kinase inhibitors in early development at Novartis

New ERK2 inhibitors with oncolytic activity reported in recent Schering-Plough patent

AstraZeneca imparts novel metabotropic glutamate receptor oxadiazole ligands

Muscarinic M3 receptor ligands and beta2-adrenoceptor agonists imparted by Argenta and AstraZeneca

CRTH2 inhibitor from Actimis active in model of allergic skin inflammation

Normal and partially transformed human embryonic stem cells differentiated

Patients with advanced gastrointestinal carcinoid tumors respond well to AMG-479

Combination of AMG-655 and gemcitabine investigated in pancreatic cancer

Brivanib plus cetuximab more effective in K-ras wild-type colorectal cancer patients

Alzheimer's Drug Discovery Foundation provides grant to Edunn Biotechnology

MMRC and Merck & Co. initiate phase II Zolinza trial in multiple myeloma

UMN confirms immunogenicity and safety of UMN-0501 influenza vaccine

Hawaii Biotech completes dosing in phase I clinical trial of West Nile vaccine

ReNeuron receives U.K. approval for ground-breaking clinical trial of ReN-001 in ischemic stroke

Janssen Pharma launches HIV drug Intelence in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...